Asthma and COPD Drugs Market
According to Intent Market Research, the Asthma and COPD Drugs Market is expected to grow from USD 30.0 billion in 2023 at a CAGR of 8.1% to touch USD 51.8 billion by 2030. The Asthma and COPD Drugs Market is dominated by key players such as GlaxoSmithKline plc, AstraZeneca plc, Novartis AG, Boehringer Ingelheim GmbH, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Sanofi S.A., Mylan N.V. (Viatris Inc.), Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd. and Regeneron Pharmaceuticals, Inc.